90 related articles for article (PubMed ID: 2757672)
1. [The disposition of bornaprine hydrochloride in the rat. 2. The metabolism of exo-epimers].
Neidlein R; Pichler B; Hege G; Weymann J
Arzneimittelforschung; 1989 May; 39(5):564-9. PubMed ID: 2757672
[TBL] [Abstract][Full Text] [Related]
2. [The disposition of bornaprine hydrochloride in the rat. 1. Pharmacokinetics: synthesis, plasma level and elimination].
Neidlein R; Pichler B; Hege G; Weymann J
Arzneimittelforschung; 1989 Apr; 39(4):484-7. PubMed ID: 2751734
[TBL] [Abstract][Full Text] [Related]
3. The metabolic fate of Sormodren (bornaprine hydrochloride) in animals and humans.
Mayo BC; Biggs SR; Chasseaud LF; Hawkins DR; Darragh A; O'Kelly DA
Xenobiotica; 1980 Dec; 10(12):873-88. PubMed ID: 7210700
[TBL] [Abstract][Full Text] [Related]
4. Microbial metabolism of bornaprine, 3-(diethylamino)propyl 2-phenylbicyclo[2.2.1]heptane-2-carboxylate.
Elmarakby SA; Clark AM; Baker JK; Hufford CD
J Pharm Sci; 1986 Jun; 75(6):614-8. PubMed ID: 3735109
[TBL] [Abstract][Full Text] [Related]
5. Anticholinergic activity of bornaprine and its metabolites in the isolated rat atrium.
Hufford CD; Elmarakby SA; Walker LA
Pharmacology; 1991; 42(1):23-7. PubMed ID: 2057518
[TBL] [Abstract][Full Text] [Related]
6. [The disposition of 2-phenyl-bicyclo[2.2.1]-heptane-2-carbonic acid (4'-diethylamino-propyl)-ester hydrochloride in the rat. 3. The metabolism of the endo-epimers of bornaprin].
Neidlein R; Pichler B; Hege G; Weymann J
Arch Pharm (Weinheim); 1988 Nov; 321(11):773-80. PubMed ID: 3219047
[No Abstract] [Full Text] [Related]
7. Pharmacokinetics and biotransformation of 2-[N-[(S)-1-ethoxycarbonyl-3-phenylpropyl]-L-alanyl]-(1S,3S, 5S)-2-azabicyclo [3.3.0]octane-3-carboxylic acid (Hoe 498) in rat, dog and man.
Eckert HG; Badian MJ; Gantz D; Kellner HM; Volz M
Arzneimittelforschung; 1984; 34(10B):1435-47. PubMed ID: 6097271
[TBL] [Abstract][Full Text] [Related]
8. [Biotransformation of 4-oxa-5-exo-(N-methylcarbamoyloxy)-tricyclo-[5.2.1.0-2, 6endo] dec-8-en-3one in the rat].
Neidlein R; Deigner HP
Arzneimittelforschung; 1988 Feb; 38(2):260-6. PubMed ID: 3370074
[TBL] [Abstract][Full Text] [Related]
9. The metabolism of 14C-cibenzoline in dogs and rats.
Loh AC; Williams TH; Tilley JW; Sasso GJ; Szuna AJ; Carbone JJ; Toome V; Leinweber FJ
Drug Metab Dispos; 1986; 14(3):325-30. PubMed ID: 2872033
[TBL] [Abstract][Full Text] [Related]
10. Excretion and biotransformation of ketanserin after oral and intravenous administration in rats and dogs.
Meuldermans W; Hendrickx J; Lauwers W; Swysen E; Hurkmans R; Knaeps F; Woestenborghs R; Heykants J
Drug Metab Dispos; 1984; 12(6):772-81. PubMed ID: 6150829
[TBL] [Abstract][Full Text] [Related]
11. Disposition and metabolism of indeloxazine hydrochloride, a cerebral activator, in rats.
Kamimura H; Enjoji Y; Sasaki H; Kawai R; Kaniwa H; Niigata K; Kageyama S
Xenobiotica; 1987 Jun; 17(6):645-58. PubMed ID: 3630201
[TBL] [Abstract][Full Text] [Related]
12. Comparative metabolic disposition of oral doses of omeprazole in the dog, rat, and mouse.
Hoffmann KJ; Renberg L; Olovson SG
Drug Metab Dispos; 1986; 14(3):336-40. PubMed ID: 2872035
[TBL] [Abstract][Full Text] [Related]
13. Metabolism and disposition of 3-amino-1,5-dihydro-5-methyl-1-beta-D-ribofuranosyl-1,4,5,6, 8-pentaazaacenaphthylene in the rat.
Basseches PJ; Powis G
Cancer Res; 1984 Sep; 44(9):3672-8. PubMed ID: 6540141
[TBL] [Abstract][Full Text] [Related]
14. Biotransformation of epomediol. I--Isolation and identification of main metabolites in the rat.
Ventura P; Selva A
Biomed Mass Spectrom; 1982 Jan; 9(1):18-21. PubMed ID: 7059659
[TBL] [Abstract][Full Text] [Related]
15. Disposition and metabolism of rifapentine, a rifamycin antibiotic, in mice, rats, and monkeys.
Emary WB; Toren PC; Mathews B; Huh K
Drug Metab Dispos; 1998 Aug; 26(8):725-31. PubMed ID: 9698285
[TBL] [Abstract][Full Text] [Related]
16. [Bornaprine in the treatment of parkinsonian tremor].
Piccirilli M; D'Alessandro P; Testa A; Piccinin GL; Agostini L
Riv Neurol; 1985; 55(1):38-45. PubMed ID: 3895365
[TBL] [Abstract][Full Text] [Related]
17. Disposition, metabolism, and excretion of the anticancer agent crisnatol in the rat.
Patel DK; Woolley JL; Shcokcor JP; Johnson RL; Taylor LC; Sigel CW
Drug Metab Dispos; 1991; 19(2):491-7. PubMed ID: 1676660
[TBL] [Abstract][Full Text] [Related]
18. Metabolic fate of the thrombolytic agent benzarone in man: comparison with the rat and dog.
Wood SG; John BA; Chasseaud LF; Bonn R; Grote H; Sandrock K; Darragh A; Lambe RF
Xenobiotica; 1987 Jul; 17(7):881-96. PubMed ID: 3660858
[TBL] [Abstract][Full Text] [Related]
19. [Pharmacokinetics of hemantane in rats].
Litvin EA; Bastrygin DV; Kolyvanov GB; Alekseev KV; Zherdev VP
Eksp Klin Farmakol; 2011; 74(11):24-8. PubMed ID: 22288156
[TBL] [Abstract][Full Text] [Related]
20. Metabolism and disposition of sulfinalol in laboratory animals.
Benziger DP; Fritz A; Edelson J
Drug Metab Dispos; 1981; 9(6):493-8. PubMed ID: 6120804
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
